These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 37950731)

  • 1. TJP3 promotes T cell immunity escape and chemoresistance in breast cancer: a comprehensive analysis of anoikis-based prognosis prediction and drug sensitivity stratification.
    Chaojun L; Pengping L; Yanjun L; Fangyuan Z; Yaning H; Yingbo S; Qi C; Hui L
    Aging (Albany NY); 2023 Nov; 15(22):12890-12906. PubMed ID: 37950731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anoikis regulator GLI2 promotes NC cell immunity escape by TGF-β-mediated non-classic hedgehog signaling in colorectal cancer: based on artificial intelligence and big data analysis.
    Shanshan Z; Fanfei D; Xuan S; Huina L; Ye Z; Jiayu L; Shuo Z; Xue P; Yingye P; Chengjun J; Hang P; Li L
    Aging (Albany NY); 2023 Dec; 15(24):14733-14748. PubMed ID: 38159250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CDKN2A was a cuproptosis-related gene in regulating chemotherapy resistance by the MAGE-A family in breast cancer: based on artificial intelligence (AI)-constructed pan-cancer risk model.
    Wan H; Yang X; Sang G; Ruan Z; Ling Z; Zhang M; Liu C; Hu X; Guo T; He J; Liu D; Pei J
    Aging (Albany NY); 2023 Oct; 15(20):11244-11267. PubMed ID: 37857018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of anoikis-related subtypes and development of risk stratification system in skin cutaneous melanoma.
    Tian J; Cao ZJ; Zhang Y; Zhou JK; Yang L
    Heliyon; 2023 May; 9(5):e16153. PubMed ID: 37215879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic analyses of genes associated with anoikis in breast cancer.
    Cao J; Ma X; Zhang G; Hong S; Ma R; Wang Y; Yan X; Ma M
    PeerJ; 2023; 11():e15475. PubMed ID: 37842046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of the prognostic value in lung adenocarcinoma based on anoikis-related genes and initial experimental validation.
    Guo W; Zhao G; Liu S; Deng T; Zhang G; Zhang B
    J Gene Med; 2023 Sep; 25(9):e3534. PubMed ID: 37259225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anoikis-related mRNA-lncRNA and DNA methylation profiles for overall survival prediction in breast cancer patients.
    Yang H; Qiu W; Liu Z
    Math Biosci Eng; 2024 Jan; 21(1):1590-1609. PubMed ID: 38303479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel stratification framework based on anoikis-related genes for predicting the prognosis in patients with osteosarcoma.
    Zhang X; Wen Z; Wang Q; Ren L; Zhao S
    Front Immunol; 2023; 14():1199869. PubMed ID: 37575253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a prognostic model to predict BLCA based on anoikis-related gene signature: preliminary findings.
    Zhu S; Zhao Q; Fan Y; Tang C
    BMC Urol; 2023 Dec; 23(1):199. PubMed ID: 38049825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pan-Cancer Analysis of PARP1 Alterations as Biomarkers in the Prediction of Immunotherapeutic Effects and the Association of Its Expression Levels and Immunotherapy Signatures.
    Zhang X; Wang Y; A G; Qu C; Chen J
    Front Immunol; 2021; 12():721030. PubMed ID: 34531868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and verification of a novel anoikis-related gene signature with prognostic significance in clear cell renal cell carcinoma.
    He Z; Gu Y; Yang H; Fu Q; Zhao M; Xie Y; Liu Y; Du W
    J Cancer Res Clin Oncol; 2023 Oct; 149(13):11661-11678. PubMed ID: 37402968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A signature based on anoikis-related genes for the evaluation of prognosis, immunoinfiltration, mutation, and therapeutic response in ovarian cancer.
    Duan Y; Xu X
    Front Endocrinol (Lausanne); 2023; 14():1193622. PubMed ID: 37383389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PTPRC promoted CD8+ T cell mediated tumor immunity and drug sensitivity in breast cancer: based on pan-cancer analysis and artificial intelligence modeling of immunogenic cell death-based drug sensitivity stratification.
    Li P; Wang W; Wang S; Cao G; Pan T; Huang Y; Wan H; Zhang W; Huang Y; Jin H; Wang Z
    Front Immunol; 2023; 14():1145481. PubMed ID: 37388747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Establishment and validation of a novel anoikis-related prognostic signature of clear cell renal cell carcinoma.
    Liu Y; Shi Z; Zheng J; Zheng Z; Sun H; Xuan Z; Bai Y; Fu M; Du Y; Shao C
    Front Immunol; 2023; 14():1171883. PubMed ID: 37056778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Membrane associated collagen XIII promotes cancer metastasis and enhances anoikis resistance.
    Zhang H; Fredericks T; Xiong G; Qi Y; Rychahou PG; Li JD; Pihlajaniemi T; Xu W; Xu R
    Breast Cancer Res; 2018 Oct; 20(1):116. PubMed ID: 30285809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of anoikis-based molecular heterogeneity in pancreatic cancer and pancreatic neuroendocrine tumor and its association with tumor immune microenvironment and metabolic remodeling.
    Li N; Jia X; Wang Z; Wang K; Qu Z; Chi D; Sun Z; Jiang J; Cui Y; Wang C
    Front Endocrinol (Lausanne); 2023; 14():1153909. PubMed ID: 37234801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical value of anoikis-related genes and molecular subtypes identification in bladder urothelial carcinoma and
    Dong Y; Xu C; Su G; Li Y; Yan B; Liu Y; Yin T; Mou S; Mei H
    Front Immunol; 2023; 14():1122570. PubMed ID: 37275895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel anoikis-related gene prognostic signature and its correlation with the immune microenvironment in colorectal cancer.
    Xiao Y; Zhou H; Chen Y; Liu L; Wu Q; Li H; Lin P; Li J; Wu J; Tang L
    Front Genet; 2023; 14():1186862. PubMed ID: 37323657
    [No Abstract]   [Full Text] [Related]  

  • 19. Identification of anoikis-related molecular patterns to define tumor microenvironment and predict immunotherapy response and prognosis in soft-tissue sarcoma.
    Qi L; Chen F; Wang L; Yang Z; Zhang W; Li ZH
    Front Pharmacol; 2023; 14():1136184. PubMed ID: 36937870
    [No Abstract]   [Full Text] [Related]  

  • 20. MicroRNA-200a promotes anoikis resistance and metastasis by targeting YAP1 in human breast cancer.
    Yu SJ; Hu JY; Kuang XY; Luo JM; Hou YF; Di GH; Wu J; Shen ZZ; Song HY; Shao ZM
    Clin Cancer Res; 2013 Mar; 19(6):1389-99. PubMed ID: 23340296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.